Endovascular treatment of type B dissection in patients with marfan syndrome: Mid‐term outcomes and aortic remodeling

Guering Eid‐Lidt, Jorge Gaspar, Gabriela Meléndez‐Ramírez, Jorge Cervantes S., Héctor González‐Pacheco, Félix Damas de los Santos, Aloha Meave‐González, Samuel Ramírez Marroquín

Catheterization and Cardiovascular Interventions · 2013 · 59 citations · 24 references

Abstract

Our results suggest that TEVAR is feasible, safe, and associated with a high reintervention rate and reduced rate of positive aortic remodeling in patients with Marfan syndrome. Survival at 8 years was comparable to contemporary series of open repair.

References

24